Stem cell therapy for babies with biliary atresia
Part of Digestive system, Genetic & congenital clinical trials.
This trial tests a new treatment using stem cells from umbilical cord blood or tissue, given to infants with biliary atresia during their Kasai surgery. The goal is to improve liver function and reduce the need for a liver transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be between 30 and 90 days old.
- Your baby must be diagnosed with biliary atresia, confirmed during surgery.
- Your baby must be scheduled for Kasai portoenterostomy surgery at Cipto Mangunkusumo Hospital.
- A parent or legal guardian must give written permission for the baby to participate.
- Your baby cannot have other heart problems or Down syndrome.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving umbilical cord stem cells during early Kasai surgery (a procedure to help drain bile) improves outcomes for infants with biliary atresia. It may help your baby's liver function and overall health.
This study tests a medicine called GCSF (helps make white blood cells) in babies who have had Kasai surgery for biliary atresia. It aims to see if GCSF can improve liver function and overall outcomes.
This study tests whether a special nutrition plan helps babies with biliary atresia recover better after Kasai surgery. It is for infants under 3 months old who are ready for surgery.
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
This trial tests whether stem cells from donated umbilical cords can help people with acute-on-chronic liver failure, a sudden worsening of chronic liver disease. The goal is to see if this treatment improves liver function and survival.
This study tests a new treatment using stem cells for people with liver cirrhosis caused by alcohol, hepatitis B, or hepatitis C. The goal is to see if it is safe and if it can help improve liver function.
Hear when a new Biliary Atresia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.